Labetalol and foetal growth retardation Patient Reports February 12, 2012

Labetalol Side Effects Report #5804030-4
Labetalol side effect was reported by a Health Professional from UNITED KINGDOM on June 23, 2008. Male patient, weighting 1.32 lb, was treated with Labetalol. After drug was administered, patient experienced the following side effects: caesarean section, foetal growth retardation, pregnancy induced hypertension. Labetalol dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, FERROUS SULPHATE, METHYLDOPA, NIFEDIPINE, ACETAMINOPHEN. Patient recovered.

Labetalol Side Effects Report #6070457-1
Labetalol side effect was reported by a Health Professional from UNITED KINGDOM on Jan 26, 2009. Female patient, weighting 1.76 lb, was treated with Labetalol. After drug was administered, patient experienced the following side effects: blood lactic acid increased, caesarean section, foetal growth retardation, hypoglycaemia neonatal, premature baby. Labetalol dosage: MATERNAL DOSE: 100 MG BID, TRANSPLACENTAL. During the same period patient was treated with HYDRALAZINE, METHYLDOPA, ACETYLSALICYLIC ACID SRT, BETAMETHASONE, DALTEPARIN, NIFEDIPINE, PHOSPHOLIPIDS. Patient recovered.

Labetalol Side Effects Report #6120296-8
Labetalol side effect was reported by a Health Professional from UNITED KINGDOM on Feb 25, 2009. Female patient, weighting 1.74 lb, was diagnosed with blood pressure increased and was treated with Labetalol. After drug was administered, patient experienced the following side effects: blood glucose abnormal, caesarean section, foetal growth retardation, hypoglycaemia. Labetalol dosage: 100 MG; DAILY; TRANS PLACENTAL. During the same period patient was treated with HYDRALAZINE, METHYLDOPA, NIFEDIPINE, ACETYLSALICYLIC ACID, BETAMETHASONE, DALTEPARIN, PHOSPHOLIPIDS. Patient recovered.